| |
CINP is pleased that its relationship with Oxford University Press (OUP), as the publisher of our official Journal, the International Journal of Neuropsychopharmacology (IJNP), has progressed very nicely since its inception in 2015. The move to OUP was associated with the IJNP becoming a fully open-access journal. This has expedited articles being published more rapidly but has also broadened its availability to investigators world-wide and increased those with access to it. Evidence for this is that the total number of downloads of our articles has increased almost fourfold and now averages about 52,000/month, according to Editor-in-Chief Alan Frazer (photo).
If you would like to submit an article, please read the author guidelines before uploading. A benefit to being a CINP member with respect to the open access fee is provided, being $1500 per article for members but $2200/article for non-members.
|
The central focus of the International Journal of Neuropsychopharmacology (IJNP)
is on research that advances understanding of existing and new
neuropsychopharmacological agents including their mode of action and
clinical application or provides insights into the biological basis of
psychiatric disorders and thereby advances their pharmacological
treatment.
IJNP has an Impact Factor of 4.207 and a 5-year Impact
Factor of 4.390 according to the most recent Journal Citation Reports®
(Thomson Reuters). This places the journal 42 out of 261 in the category
of Pharmacology & Pharmacy. The Impact Factor is the average number
of times articles from the journal published in the past two years have
been cited in the JCR year. The Impact Factor is calculated by dividing
the number of citations in the JCR year by the total number of articles
published in the two previous years. The five-year Impact Factor is
calculated in the same way as the standard Impact Factor, except the
standard two-year window for inclusion of articles is extended to five
years. Current statistics about the Journal are shown in the infographic
and illustrate the rapid speed of online publication from final
acceptance of the article.
Professor Siegfried Kasper, current CINP
president, stated, “IJNP has been an important part of the life of the
CINP and a venue for the publication of outstanding and impactful
science. Under the leadership of our editor-in-chief, Alan Frazer, our
outstanding collaboration with Oxford University Press is helping us to
increase the visibility of papers appearing in IJNP. It is also making
IJNP more user-friendly for both contributing authors and readers.” IJNP’s focus is on research which advances the understanding of
neuropsychopharmacological agents and more novel treatment modalities
such as stimulation approaches, including their clinical applications,
or which provides insights into the biological basis of neuropsychiatric
disorders and thereby advances their treatment.
Past Issues
You can find all IJNP issues from the past four years below. Click here to view all.
IJNP Team
To ensure high quality standards of the published articles, the IJNP Team consists of worldwide known experts in the field of neuropsychopharmachology who support the journal with their expertise in certain fields. The Editorial Board gives support in these activities and constantly reviews the submitted articles. Contact us
Edtior-in-Chief & Field Editors
Editor-in-ChiefProf. Alan Frazer (USA) Field Editor: Pre-Clinical Neuropsychopharmacology
Prof. Anthony Grace (USA)
Prof. Carla Gambarana (Italy)
Field Editor: Clinical Neuropsychopharmacology
Dr. Martin Lambert (Germany)
Field Editor: Neuroimaging
Prof. Gitte Knudsen (Denmark)
Field Editor: Molecular Genetics & TherapeuticsDr. David Goldman (USA)
Field Editor: Translational Medicine
Prof. Pierre Blier (Canada)
Field Editor: Reviews and Special Projects
Prof. Siegfried Kasper (Austria)
| |
IJNP Editorial Board
- Aleksander A. Mathé, Stockholm, Sweden
- Andrea Giuffrida, San Antonio, USA
- Angela Roberts, Cambridge, UK
- Anil Malhotra, Glen Oaks, USA
- Anita Richer-Rössler, Basel, Switzerland
- Anne Eckert, Basel, Switzerland
- Anthony West, Chicago, USA
- Astrid Linthorst, Bristol, UK
- Barbara Sahakian, Cambridge, UK
- Betty Jo Salmeron, Baltimore, USA
- Brian Dean, Victoria, Australia
- Carlo Altamura, Milan, Italy
- Celso Arango, Madrid, Spain
- Dan Rujescu, Halle, Germany
- Daniel Martins-de-Souza, Manheim, Germany
- Daniel Mueller, Toronto, Canada
- David Morilak, San Antonio, USA
- Eduard Vieta, Barcelona, Spain
- Edythe London, Los Angeles, USA
- Elena Chartoff, Boston, USA
- Eva Meisenzahl, Düsseldorf, Germany
- Felipe Fregni, Boston, USA
- Francesc Artigas, Barcelona, Spain
- Francisco Guimaraes, Sao Paulo, Brazil
- Ghanshyam Pandey, Chicago, USA
- Gustavo Turecki, Montreal, Canada
- Gustavo Vazquez, Buenos Aires, Argentina
- Henry Kranzler, Philadelphia, USA
- Janet Neisewander, Tempe, USA
- Jared Young, La Jolla, USA
- Jean Lud Cadet, Baltimore, USA
- John Cryan, Cork, Ireland
- Katharina Domschke, Wuerzburg, Germany
- Kim Do, Prilly-Lausanne, Switzerland
- Kuei Y. Tseng, Chicago, USA
- Lin Lu, Beijing, China
- Luise Poustka, Göttingen, Germany
- Maarten van den Buuse, Parkville, Australia
- Marco Pistis, Monserrato, Italy
- Maria Lindskog, Stockholm, Sweden
- Mark Underwood, New York, USA
- Mauricio Tohen, Albuquerque, USA
- Maurizio Popoli, Milan, Italy
- Melanie Porter, Macquarie, Australia
- Michael Soyka, Munich, Germany
- Michael Thase, Pittsburgh, USA
- Nicolas Singewald, Innsbruck, Austria
- Norio Ozaki, Nagoya, Japan
- Patricio O’Donnell, Baltimore, USA
- Peter Falkai, Munich, Germany
- Peter Klaus Ebmeier, Oxford, UK
- Pradeep J. Nathan, Cambridge, UK
- Rainer Spanagel, Mannheim, Germany
- Randy Gollub, Charlestown, USA
- Rebecca Elliott, Manchester, UK
- Richard Shelton, Nashville, USA
- Rupert Lanzenberger, Vienna, Austria
- Tetsuya Suhara, Anagawa, Japan
- William Wetsel, Durham, USA
- Wouter Koek, San Antonio, USA
- Yan Dong, Pittsburgh, USA
|
| | |
